INTERNATIONAL PATENT: BETH ISRAEL DEACONESS MEDICAL CENTER, INC. FILES APPLICATION FOR "METHYLATION OF THE 5-ALPHA REDUCTASE 2 (SRD5A2) GENE"

GENEVA, Aug. 26 -- BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (330 Brookline AvenueBoston, Massachusetts 02215) filed a patent application (PCT/US2025/015787) for "METHYLATION OF THE 5-ALPHA REDUCTASE 2 (SRD5A2) GENE" on Feb 13, 2025. With publication no. WO/2025/175002, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): OLUMI, Aria F. (330 Brookline AvenueBoston, Massachusetts 02215)

Abstract: Provided herein are methods of treating a subject having benign prostatic hyperplasia that include, for example, identifying a su...